TRS 961 - Annex 4: WHO good manufacturing practices for blood establishments (jointly with the Expert Committee on Biological Standardization)

Overview

The aim of these explanatory notes is to guide the manufacturer of medicinal products in the preparation of an SMF that is useful to the regulatory authority in planning and conducting GMP inspections.